José-Juan
Pereyra-Rodríguez
Publicaciones en las que colabora con José-Juan Pereyra-Rodríguez (22)
2024
-
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up
Dermatitis, Vol. 35, pp. S55-S61
-
Real-World Safety and Efficacy Profile of Baricitinib in Patients With Atopic Dermatitis: a Multicenter Retrospective Trial From Four Spanish Hospitals in Andalusia
Actas Dermo-Sifiliograficas
2023
-
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
Acta Dermato-Venereologica, Vol. 103
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
-
Upadacitinib for moderate to severe atopic dermatitis
Immunotherapy, Vol. 15, Núm. 11, pp. 799-808
2022
-
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)
Life
-
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
Life, Vol. 12, Núm. 8
-
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning
International journal of environmental research and public health, Vol. 19, Núm. 17
2021
-
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
Anais Brasileiros de Dermatologia, Vol. 96, Núm. 6, pp. 787-790
-
Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study
British Journal of Dermatology
-
Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis
Life, Vol. 11, Núm. 9
2020
-
A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228
-
Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain
Dermatologic Therapy, Vol. 33, Núm. 6
-
The Safety of Dupilumab in Clinical Practice: 52 Weeks of Experience at 5 Referral Hospitals in Andalusia
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 699-700
2019
-
Development and validation of a questionnaire to measure empowerment in adult patients with atopic dermatitis. The DATEMP questionnaire
JDDG - Journal of the German Society of Dermatology, Vol. 17, Núm. 9, pp. 923-931
-
Dupilumab: short-term effectiveness and security in real clinical practice – A retrospective multicentric study
Journal of the European Academy of Dermatology and Venereology
-
Entwicklung und Validierung eines Fragebogens zur Messung des Empowerments bei erwachsenen Patienten mit atopischer Dermatitis. Der DATEMP-Fragebogen
JDDG - Journal of the German Society of Dermatology, Vol. 17, Núm. 9, pp. 923-932
-
Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series
Dermatologic Therapy, Vol. 32, Núm. 4
-
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
British Journal of Dermatology
2018
-
Empowerment in Dermatology
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 2, pp. 133-139